Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)Claude Preudhomme, Hervé Dombret, C. Sagot et al.|Blood|2002Cited by 503
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaÉric Jourdan, Hervé Dombret, Odile Blanchet et al.|Blood|2013Cited by 357
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association GroupMarie Balsat, Nicolas Boissel, Aline Renneville et al.|Journal of Clinical Oncology|2017Cited by 292
Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic MalignanciesAline Renneville, Benjamin L. Ebert, Jessica A. Gasser et al.|Blood Cancer Discovery|2021Cited by 46
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 StudyRathana Kim, Emmanuelle Clappier, Yves Chalandon et al.|Journal of Clinical Oncology|2024Cited by 39